Arcus biosciences to participate at upcoming investor conferences

Hayward, calif.--(business wire)--arcus biosciences, inc. (nyse:rcus), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that management will present at the following upcoming september 2021 virtual investor conferences. citi's 16th annual virtual biopharma conference, friday, september 10 at 1:25 pm et 2021 cantor virtual global healthcare conference, monday, september 27 at 4:40 pm et a live audio webcast of the presentation will b
RCUS Ratings Summary
RCUS Quant Ranking